Cargando…

Determining SARS-CoV-2 non-infectivity state–A brief overview

From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individ...

Descripción completa

Detalles Bibliográficos
Autores principales: Brynjolfsson, Siggeir F., Sigurgrimsdottir, Hildur, Gudlaugsson, Olafur, Kristjansson, Mar, Kristinsson, Karl G., Ludviksson, Bjorn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412020/
https://www.ncbi.nlm.nih.gov/pubmed/36033758
http://dx.doi.org/10.3389/fpubh.2022.934242
_version_ 1784775397896880128
author Brynjolfsson, Siggeir F.
Sigurgrimsdottir, Hildur
Gudlaugsson, Olafur
Kristjansson, Mar
Kristinsson, Karl G.
Ludviksson, Bjorn R.
author_facet Brynjolfsson, Siggeir F.
Sigurgrimsdottir, Hildur
Gudlaugsson, Olafur
Kristjansson, Mar
Kristinsson, Karl G.
Ludviksson, Bjorn R.
author_sort Brynjolfsson, Siggeir F.
collection PubMed
description From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individual has reached a non-infectious state. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted under diverse circumstances, and various rules and regulations, along with different testing methods, have been applied in an attempt to confine the transmission. However, that has proven to be a difficult task. In this review, we take together recently published data on infectivity and transmission of SARS-CoV-2 and have combined it with the clinical experience that physicians in Iceland have accumulated from the pandemic. In addition, we suggest guidelines for determining when patients with COVID-19 reach a non-infectious state based on a combination of clinical experience, scientific data, and proficient use of available tests. This review has addressed some of the questions regarding contagiousness and immunity against SARS-CoV-2.
format Online
Article
Text
id pubmed-9412020
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94120202022-08-27 Determining SARS-CoV-2 non-infectivity state–A brief overview Brynjolfsson, Siggeir F. Sigurgrimsdottir, Hildur Gudlaugsson, Olafur Kristjansson, Mar Kristinsson, Karl G. Ludviksson, Bjorn R. Front Public Health Public Health From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and globally the pandemic rages with detrimental consequences, with the emergence of new more infectious and possibly virulent variants. A clinical obstacle in this battle has been to determine when an infected individual has reached a non-infectious state. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can be transmitted under diverse circumstances, and various rules and regulations, along with different testing methods, have been applied in an attempt to confine the transmission. However, that has proven to be a difficult task. In this review, we take together recently published data on infectivity and transmission of SARS-CoV-2 and have combined it with the clinical experience that physicians in Iceland have accumulated from the pandemic. In addition, we suggest guidelines for determining when patients with COVID-19 reach a non-infectious state based on a combination of clinical experience, scientific data, and proficient use of available tests. This review has addressed some of the questions regarding contagiousness and immunity against SARS-CoV-2. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9412020/ /pubmed/36033758 http://dx.doi.org/10.3389/fpubh.2022.934242 Text en Copyright © 2022 Brynjolfsson, Sigurgrimsdottir, Gudlaugsson, Kristjansson, Kristinsson and Ludviksson. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Brynjolfsson, Siggeir F.
Sigurgrimsdottir, Hildur
Gudlaugsson, Olafur
Kristjansson, Mar
Kristinsson, Karl G.
Ludviksson, Bjorn R.
Determining SARS-CoV-2 non-infectivity state–A brief overview
title Determining SARS-CoV-2 non-infectivity state–A brief overview
title_full Determining SARS-CoV-2 non-infectivity state–A brief overview
title_fullStr Determining SARS-CoV-2 non-infectivity state–A brief overview
title_full_unstemmed Determining SARS-CoV-2 non-infectivity state–A brief overview
title_short Determining SARS-CoV-2 non-infectivity state–A brief overview
title_sort determining sars-cov-2 non-infectivity state–a brief overview
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412020/
https://www.ncbi.nlm.nih.gov/pubmed/36033758
http://dx.doi.org/10.3389/fpubh.2022.934242
work_keys_str_mv AT brynjolfssonsiggeirf determiningsarscov2noninfectivitystateabriefoverview
AT sigurgrimsdottirhildur determiningsarscov2noninfectivitystateabriefoverview
AT gudlaugssonolafur determiningsarscov2noninfectivitystateabriefoverview
AT kristjanssonmar determiningsarscov2noninfectivitystateabriefoverview
AT kristinssonkarlg determiningsarscov2noninfectivitystateabriefoverview
AT ludvikssonbjornr determiningsarscov2noninfectivitystateabriefoverview